Clinical Report: Can automated oxygen improve titration?
Overview
The SAVE-O2 AI randomized clinical trial demonstrated that autonomous oxygen titration significantly increased the time hospitalized adults spent within the targeted normoxemia range and reduced hypoxemia compared to manual titration. The trial involved 300 patients across four US hospitals.
Background
Oxygen therapy is critical in managing patients with acute respiratory illnesses, yet improper titration can lead to hypoxemia or hyperoxemia, both of which are harmful. The SAVE-O2 AI trial aimed to evaluate the effectiveness of an autonomous oxygen titration system in maintaining optimal oxygen saturation levels in hospitalized patients.
Data Highlights
| Outcome | Autonomous Titration | Usual Care |
|---|---|---|
| Mean time in normoxemia | 85% | 63% |
| Mean time in hypoxemia | 2% | 4% |
| Mean time in hyperoxemia | 9% | 29% |
| Mean time < 85% SpO2 | 1% | 2% |
Key Findings
- Patients in the autonomous titration group spent a mean of 85% of observed time in the normoxemia range compared to 63% in the usual care group.
- Mean time spent in hypoxemia was significantly lower in the autonomous group (2%) compared to the usual care group (4%).
- Mean time spent in hyperoxemia was reduced from 29% in usual care to 9% in the autonomous group.
- Subgroup analyses favored autonomous titration across various demographics and clinical indications.
- No serious adverse events were reported; minor discomforts were noted in the autonomous group.
Clinical Implications
No clinical implications are provided in the source material.
Conclusion
The SAVE-O2 AI trial indicates that autonomous oxygen titration can effectively maintain normoxemia and reduce hypoxemia in hospitalized patients.
Related Resources & Content
- Douin DJ, et al., JAMA Internal Medicine, 2025 -- Autonomous Oxygen Titration for Maintaining Normoxemia in Acutely Ill Adults: The SAVE-O2 AI Randomized Clinical Trial
- the pathologist — Smart Oxygen Cuvette for Optical Monitoring of Dissolved Oxygen in Biological Blood Samples
- Intensive Care Medicine — Monitoring the Oxygen Reserve Index (ORI) Reduces Hyperoxia Duration in Critically Ill Patients: Findings from the Randomized Controlled ORI2 Trial
- Critical Care — From underwater physiology to intensive care: oxygen tolerance unit at the bedside
- the analytical scientist — Connected Chemistry
- 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes
- Monitoring the Oxygen Reserve Index (ORI) Reduces Hyperoxia Duration in Critically Ill Patients
- From underwater physiology to intensive care: oxygen tolerance unit at the bedside
- Comparison of oxygenation targets in critically ill adults: a systematic review and network meta-analysis of randomized controlled trials | American Journal of Respiratory and Critical Care Medicine | Oxford Academic
- Autonomous Oxygen Titration for Maintaining Normoxemia in Acutely Ill Adults: The SAVE-O2 AI Randomized Clinical Trial | Trials | JAMA Internal Medicine | JAMA Network
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
